Japan Pricing Update: Wegovy Finally Listed, Upcoming Special Cuts For Imfinzi, Polivy

Leqembi Discussions Ongoing

 
• By Lisa Takagi

Japan adds a batch of new drugs, including Wegovy, to the national health insurance reimbursement tariff, but discussions over Leqembi for Alzheimer’s are still ongoing, with indications that repricing could be possible if demand expands quickly.

Japan pricing update
Japan has announced reimbursement prices for new drugs approved in September, but Leqembi talks ongoing • Source: Shutterstock

More from Japan

More from Asia